Mast Cell Disorders In Drug Hypersensitivity

Author(s): Patrizia Bonadonna, Massimiliano Bonifacio, Roberta Zanotti.

Journal Name: Current Pharmaceutical Design

Volume 22 , Issue 45 , 2016

Become EABM
Become Reviewer

Abstract:

Mastocytosis is a clonal disease characterized by proliferation and accumulation of mast cells (MC) in different tissues, preferentially skin and bone marrow, leading to a wide variety of clinical manifestations, mainly caused by the inappropriate release of MC mediators. As a consequence, patients with mastocytosis may experience symptoms due to massive MC activation and release of mediators. Anaphylaxis is the most frequent manifestation of this phenomenon. Drugs are possible triggers of anaphylaxis in patients with mastocytosis, even though the association between mastocytosis and drug anaphylaxis does not appear to be as strong as anaphylaxis after hymenoptera sting; nevertheless, MC disorders might be ruled out in cases of severe systemic reactions to drugs. Moreover, the risk of perioperative anaphylaxis in adults appears high, mainly in patients with indolent systemic mastocytosis regardless of skin involvement. Such risk is probably lower in patients who have never experienced anaphylaxis and/or have tolerated previous general anaesthesia. However, data published about drug anaphylaxis in patients with MC disorders are scanty and currently it is not possible to provide clear recommendations.

Keywords: Mastocytosis, drug allergy, tryptase, mast cell.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 22
ISSUE: 45
Year: 2016
Page: [6862 - 6869]
Pages: 8
DOI: 10.2174/1381612822666160928121857
Price: $58

Article Metrics

PDF: 28
HTML: 2
EPUB: 1
PRC: 2